New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2021, WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia.
View latest version (2021)Bibliographic Info
GuidelineWHO recommendations for prevention and treatment of pre-eclampsia and eclampsia
Year of Publication2011
Issuing InstitutionWorld Health Organization
Recommendation
Status
Retired
Recommended in favor
Strong
Certainty of evidence
Moderate
Low-dose acetylsalicylic acid (aspirin, 75 mg per day) for the prevention of pre-eclampsia and its related complications for (Pregnant) women